Copyright
©The Author(s) 2025.
World J Stem Cells. Jun 26, 2025; 17(6): 106272
Published online Jun 26, 2025. doi: 10.4252/wjsc.v17.i6.106272
Published online Jun 26, 2025. doi: 10.4252/wjsc.v17.i6.106272
Figure 4 Expression of CD62p on platelet surfaces, as shown by flow cytometry.
A: The expression rate of CD62p in the low-altitude group was 14.3%; B: The expression rate of CD62p in the high-altitude group was 20.1%; C: The expression rate of CD62p in the human umbilical cord mesenchymal stem cell group was 14.4%; D: The expression rate of CD62p in low-altitude group, high-altitude group, and human umbilical cord mesenchymal stem cell group. n = 8 in each group. dP < 0.0001. hUC-MSC: Human umbilical cord mesenchymal stem cell.
- Citation: Zhang B, Gao BD, Su Y, Mi WJ, Zeng TX, Ma FF, Ha XQ. Human umbilical cord mesenchymal stem cells reduce platelet α-granule release in rats via the AKT/MEK/ERK pathway during acute exposure to high-altitude hypoxia. World J Stem Cells 2025; 17(6): 106272
- URL: https://www.wjgnet.com/1948-0210/full/v17/i6/106272.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i6.106272